Abstract
Interventional occluder implantation has become the preferred mode of treatment in children with clinically significant atrial septal defect (ASD). The continuous increase in the number of patients treated calls for long-term data on device integrity and biocompatibility. We report a child who underwent successful interventional ASD closure at age 5 years. Secondary residual shunt occurred after 3 years of follow-up, and surgical ASD closure became necessary at age 12 years. The Amplatzer occluder device, which was removed after 7 years in vivo, showed no signs of mechanical failure, corrosion, or clinically relevant immunological response at the device–tissue interface.
References
Ding ZR, Qin YW, Hu JQ et al (2009) A new pan-nitinol occluder for transcatheter closure of ventricular septal defects in a canine model. Interv Cardiol 22:191–198
Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K, Amplatzer Investigators (2002) Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: Results of a multicenter nonrandomized trial. Am Coll Cardiol 39:1836–1844
Kong H, Wilkinson JL, Coe JY et al (2002) Corrosive behaviour of Amplatzer devices in experimental and biological environments. Cardiol Young 12:260–265
Masura J, Gavora P, Formanek A, Hijazi ZM (1997) Transcatheter closure of secundum atrial septal defects using the new self-centering Amplatzer septal occluder: Initial human experience. Cathet Cardiovasc Diagn 42:388–393
Masura J, Gavora P, Podnar T (2005) Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders. J Am Coll Cardiol 45:505–507
Omeish A, Hijazi ZM (2001) Transcatheter closure of atrial septal defects in children and adults using the Amplatzer septal occluder. Interv Cardiol 14:37–44
Sharafuddin MJ, Gu X, Titus JL et al (1997) Transvenous closure of secundum atrial septal defects: preliminary results with a new self-expanding nitinol prosthesis in a swine model. Circulation 95:2162–2168
Sigler M, Jux C (2007) Biocompatibility of septal defect closure devices. Heart 93:444–449
Sigler M, Paul T, Grabitz RG (2005) Biocompatibility screening in cardiovascular implants. Z Kardiol 94:383–391
Sigler M, Jux C, Ewert P (2006) Histopathological workup of an Amplatzer atrial septal defect occluder after surgical removal. Pediatr Cardiol 27:775–776
Xiangqing K, Kejiang C, Rong Y et al (2002) Transcatheter closure of secundum atrial septal defects using Amplatzer septal occluder. Chin Med 115:126–128
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Movie clip 1. (A and B) Transthoracic echocardiographic follow-up examination from 2005. A trans-septal flow signal was detected next to the inferior margin of the Amplatzer occluder for the first time after 3 years of follow-up as demonstrated from two different angles
Movie clip 1. (A and B) Transthoracic echocardiographic follow-up examination from 2005. A trans-septal flow signal was detected next to the inferior margin of the Amplatzer occluder for the first time after 3 years of follow-up as demonstrated from two different angles
Movie clip 2. Transthoracic echocardiographic follow-up from 2008. Progression in size of the secondary ASD was documented on follow-up examinations between 2005 and 2008. The secondary ASD reached 10 mm in diameter by 2009, with the Amplatzer occluder still in situ, and eventually required surgical closure
Rights and permissions
About this article
Cite this article
Zhu, W., Neubauer, H. Secondary Residual Shunt After Atrial Septal Defect Closure With an Amplatzer Occluder: Surgical Removal and Evaluation of Device Biocompatibility After 7 Years. Pediatr Cardiol 31, 1107–1110 (2010). https://doi.org/10.1007/s00246-010-9757-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-010-9757-y